Evogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule
13 February 2017 - 11:02PM
Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology
company for the improvement of crop productivity, announced today
that it will release its financial results for the fourth quarter
and full year 2016 on Monday, February 27, 2017.
On the day of the announcement, the Company’s
management will host a conference call to discuss the results at
09:00 AM Eastern time, 16:00 Israel time. To access the conference
call, please dial 1-888-407-2553 toll free from the United States,
or +972-3-918-0610 internationally. Access to the call will also be
available via live webcast through the Company’s website at
www.evogene.com.
A replay of the conference call will be
available approximately three hours following the completion of the
call. To access the replay, please dial 1-888-782-4291 toll free
from the United States, or +972-3-925-5901 internationally. The
replay will be accessible through March 1, 2017, and an archive of
the webcast will be available on the Company’s website through
March 10, 2017.
About Evogene Ltd.:Evogene (NASDAQ:EVGN)
(TASE:EVGN) is a leading biotechnology company for the improvement
of crop productivity for the food, feed and fuel industries. The
Company operates in three key market segments: improved seed traits
(addressing yield and resistance to diseases and environmental
stresses); innovative ag-chemicals (developing novel herbicide
solutions for weed control); and ag-biologicals. Evogene has
collaborations with world-leading seed and ag-chemical companies.
For more information, please visit www.evogene.com or contact the
Company at info@evogene.com.
This press release contains "forward-looking
statements" relating to future events. These statements
may be identified by words such as "may", "could",
“expects”, "intends", “anticipates”,
“plans”, “believes”, “scheduled”, “estimates” or words of
similar meaning. Such statements are based on current
expectations, estimates, projections and assumptions,
describe opinions about future events, involve certain
risks and uncertainties which are difficult to predict and are
not guarantees of future performance. Therefore, actual future
results, performance or achievements of Evogene may differ
materially from what is expressed or implied
by such forward-looking statements due to a variety of
factors, many of which beyond Evogene's
control, including, without limitation, those risk
factors contained in Evogene’s reports filed with the
appropriate securities authority. Evogene disclaims any
obligation or commitment to update these forward-looking statements
to reflect future events or developments or changes in
expectations, estimates, projections and assumptions.
Contact:
Karen Mazor, Director Investor Relations
E: IR@evogene.com
T: +972 54 228 8039
Evogene, Ltd. (NYSE:EVGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Evogene, Ltd. (NYSE:EVGN)
Historical Stock Chart
From Sep 2023 to Sep 2024